Association of mortality and phase angle measured by different bioelectrical impedance analysis (BIA) devices

No prior work had resolved if diverse impedance devices yield consistent prognostic data for aging populations. It was already known that high phase angle values correlate with improved survival outcomes in geriatric patients. That uncertainty drove researchers to examine if specific hardware variations alter these clinical predictions. Prior research has shown that cellular integrity influences overall physiological resilience in older individuals. This gap motivated a comprehensive review of multiple measurement tools within a single hospital setting. Scientists often rely on these metrics to assess nutritional status and systemic health. Previous investigations primarily focused on single-device performance rather than comparative analysis across platforms. This study addresses the need for standardized interpretation of impedance data in clinical practice.

This study aims to determine if the association between high phase angle and reduced mortality persists across different impedance measurement devices. Researchers sought to validate whether these findings remain consistent when using various hardware platforms commonly found in hospital settings. The team addressed the need to confirm if cellular health markers provide reliable prognostic information for aging populations. They investigated whether specific equipment variations influence the clinical utility of these measurements. This effort was motivated by the desire to standardize health assessments for patients aged 65 and older. The researchers examined data from a large cohort to ensure robust statistical power for their comparisons. By analyzing multiple devices, the study clarifies the generalizability of phase angle as a health indicator. The authors intended to provide evidence that supports the broader application of these metrics in geriatric clinical practice.

The researchers conducted a retrospective analysis of clinical data collected from 1990 to 2011 at Geneva University Hospitals. They identified all patients aged 65 or older who underwent impedance testing during this period. The team categorized participants based on the specific hardware used for their assessment. They utilized the Cumulative Illness Rating Scale to document the health status of each participant at the time of testing. Survival outcomes were tracked by retrieving death records through December 2012. The investigators organized phase angle values into sex-specific quartiles to facilitate comparative analysis. They applied Cox regression models to evaluate the link between these quartiles and patient survival. The approach ensured that potential confounders like body mass index were considered in the final statistical evaluation.

The strongest finding indicates that higher phase angle quartiles correlate with a progressive reduction in death risk among older adults. Patients measured with the Bio-Z device showed hazard ratios of 0.36 in women and 0.38 in men for the fourth quartile. Those assessed using the RJL-101 device demonstrated even lower hazard ratios of 0.23 for women and 0.19 for men. These results remained statistically significant with p-values below 0.001 for both devices. The researchers observed that the association persisted even after adjusting for age, body mass index, and comorbidities. Limited sample sizes for the Eugedia and Xitron 4000B devices precluded the completion of multivariate regression models for those groups. The study confirmed that the predictive value of the metric is consistent across the two primary devices with sufficient data. Overall, 1,151 deaths occurred among the 1,878 participants included in the final analysis.

The authors propose that high phase angle values consistently predict reduced mortality risk in older adults. This association remains robust even after adjusting for age, body mass index, and existing comorbidities. The researchers conclude that the predictive power of this metric holds across different impedance hardware platforms. Their findings suggest that clinicians can utilize these measurements to assess health status in aging patients. The study highlights the utility of this marker in identifying individuals at higher risk for poor outcomes. The researchers note that limited sample sizes for certain devices prevented comprehensive multivariate analysis in those specific groups. Their work supports the broader application of impedance-based screening in geriatric care settings. These results provide evidence that cellular health indicators remain relevant across diverse diagnostic technologies.